Light Therapy and Retinal Damage

Ocular Experts Caution Against the Use of Bright Light and Blue Light Therapy Lamps

Many experts link the development of Age-related Macular Degeneration (AMD) with the cumulative lifetime exposure to blue light wavelengths. Dr. S. Beatty, director of the Macular Pigment Pigment Research Group (MPRG) stated "It is photo-oxidative stress, or the cumulative exposure to free radicals from blue light over a lifetime that causes AMD". The European Eye (EUREYE) Study found that "the combination of blue light exposure and low plasma concentrations of antioxidants was also associated with the early stages of AMD, which are common in the population, and that blue light exposure in middle age might be more damaging than at younger ages." Studies have indicated that a moderate increase in lifetime exposure to blue light can advance the onset of this blinding disease by several years.

While Lo-LIGHT lamps, which do not emit blue light cannot damage the eye, several experts in retinal damage caution against the use of bright and blue light therapy lamps. Drs. JE Roberts and AR Wielgus, reviewed "the underlying reasons why visible light in general and short blue visible light in particular dramatically raises the risk of photodamage to the human retina", and stated "Intense visible light sources that do not filter short blue visible light used for phototherapy of circadian imbalance (i.e. Seasonal Affective Disorder) increase the risk for age-related light damage to the retina." [J. Photochemistry and Photobiology 88;6 1320-45]

Drs. L. Lack and H. Wright, experts in the spectral sensitivity of humans to light therapy, provided the following caution in the journal Behavioral Sleep Medicine to researchers and users of bright light therapy "It should be noted that broad-spectrum white light, traditionally used for bright light therapy, also contains blue light of potential concern particularly for very high intensity, long- duration exposure. Clearly, the safety of bright light therapy for people needs investigating. In the meantime it would be suggested that light in the 500 to 530 nm wavelength range (blue-green) should still be effective while avoiding the putative blue hazard." Gagne et al, from the Department of Ophthalmology at Laval University concluded "The main finding of this experiment is that blue light reduces photoreceptor responses after only a single administration. This brings important concerns with regard to blue-enriched light therapy lamps used to treat SAD symptoms and other disorders."[Progress in Neuropsychopharmacological and Biological Psychiatry]

Potential Harm for Users of Light Therapy from Exposure to Blue Light

The consequences of AMD for people who use light therapy can be severe. On the 25th anniversary of the development of light therapy, the journal Science reported on the first person treated by bright light therapy for winter depression, who described how light therapy became less and less effective for him over the years as his eyesight faded, and concluded "Now I can hardly see, and all hell has broken loose... I have had periods of depression lasting over a year".

We believe it can now be established that the accumulated exposure of the eye to blue light over a lifetime is a strongly contributing factor to the development of AMD. Studies also confirm that the hazardous shorter wavelengths of visible light constituting the blue portion of the spectrum, (i.e visible light with wavelengths shorter than 480 nm) are not more effective for light therapy than the longer wavelengths of visible light in the 555 nm range. (Read more), Since wavelengths of light in the region of 500 to 505 nm pose much less of a hazard to the retina than blue light wavelengths, and since wavelengths of light around 500 nm have been found to be at least ten times as effective for light therapy than blue light wavelengths, the use of light therapy lamps that emit high proportions of blue light does not appear to be justifiable.

Sunnex Biotechnologies low intensity Lo-LIGHT therapy lamps are the safe alternative. Proven effective in independent studies published in several highly rated peer-reviewed journals by a number of different research groups, Lo-LIGHT lamps provide light therapy at the intensity and brightness levels normally found in a well-lit office. In addition to filtering out hazardous ultraviolet(UV) light which can damage the lens or cornea and cause cataracts, the Lo-LIGHT also screens out the visible light wavelengths that are most hazardous to the retina. Those wavelengths are in the blue portion of the visible light spectrum with a wavelength shorter than 480 nm. Since blue wavelengths are also emitted by white light lamps normally used for indoor lighting, the Lo-LIGHT is less hazardous to the eye than regular indoor lighting.

It is the combination of low intensity and the filtering out of the hazardous visible blue light wavelengths, {wavelengths shorter than 485 nm}, of the light provided by a Lo-LIGHT lamp that eliminates the risk of eye damage that is inherent in the use of "bright" white light or blue light therapy lamps. However, even the relatively safe wavelengths of light sources providing light wavelengths in the region of 500 nm provided by a Lo-LIGHT may be hazardous at high intensities. Although the soft green glow from a Lo-LIGHT lamp providing less than 400 lux is comfortable, effective, and safe, we believe other commercial light therapy devices that provides 8,000 to 12,000 lux of blue-green light of similar wavelengths may pose a hazard to the eye.

Click here for more detailed discussions on Retinal Damage and Light Therapy Lamps with links to the references for the quotes cited on this page.


Purchase or "No Risk" Rental Plans

In North America, a no-risk rental program is available on some models. If the unit is purchased within 2 months from the time of rental, all rental payments are applied towards the purchase price. Order Now! Order Now!

The Sunnex Biotechnologies Lo-LIGHT phototherapy lamp comes with a five year warranty. Details